Dr. Richard Rainey Discusses Coverage Decisions and Genetic Testing

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions.

Age-Related Disparities in ADC Treatment Rates in Breast Cancer with Tabby Khan, MD

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

A new analysis from Komodo Health pinpointed significant disparities by age and insurance in antibody-drug conjugate (ADC) treatment rates for metastatic breast cancer.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

CAR T-cell therapy | Image Credit: Funny -stock.adobe.com

Real-World Evidence Standards Bridge Research, Clinical Decision-Making: Cate Lockhart, PharmD, PhD

Experts at AMCP Nexus 2025 highlighted how real-world data can improve CAR T-cell therapy access and outcomes.

Culturally Competent Menopause Care: Lisa Taylor-Swanson, PhD

Real-world evidence helps pharmaceutical companies and payers communicate more effectively.

Related Content

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions.

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

A new analysis from Komodo Health pinpointed significant disparities by age and insurance in antibody-drug conjugate (ADC) treatment rates for metastatic breast cancer.

Listen

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Real-World Evidence Standards Bridge Research, Clinical Decision-Making: Cate Lockhart, PharmD, PhD

Experts at AMCP Nexus 2025 highlighted how real-world data can improve CAR T-cell therapy access and outcomes.